Federal award (DEFINITIVE CONTRACT, fiscal year 2022)
Recipient: CUBRC, INC.
Awarding agency: Department of Health and Human Services / Food and Drug Administration
Funding agency: Department of Health and Human Services / Food and Drug Administration
Period of performance: 2018-09-18 to 2020-07-31
Current total value of award: $992041.29
Description: IMMUNOGENICITY RISK OF PEPTIDE DRUG GENERICS AND THEIR IMPURITIES: IN SILICO AND IN VITRO ASSESSMENT AND VALIDATION METHODS